Sermorelin studies: 101 papers with results
Page 2 of 3
- Effect of long-term GHRH and somatostatin administration on GH release and body weight in prepubertal female rats.
Pérez-Romero A · Journal of physiology and biochemistry · 1999
Animal study (in vivo) · rat · 8 results
- Synergism and diurnal variations of human growth hormone-releasing factor (1-29)NH2 and thyrotropin-releasing factor on growth hormone release in dairy calves.
Lapierre H · Domestic animal endocrinology · 1987
Animal study (in vivo) · dairy calves (holstein) · 4 results
- Interactions of GRF(1-29)NH2 with plasma proteins and their effects on the release of the peptide from a PLAGA matrix.
Mariette B · Journal of controlled release : official journal of the Controlled Release Society · 2005
Animal study (in vivo) · rat · 6 results
- In vitro stability of growth hormone releasing factor (GRF) analogs in porcine plasma.
Su CM · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 1991
Ex vivo tissue · pig · 3 results
- The involvement of dipeptidyl peptidase IV in brush-border degradation of GRF(1-29)NH2 by intestinal mucosal cells.
Bai JP · The Journal of pharmacy and pharmacology · 1995
Ex vivo tissue · rat · 2 results
- The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture.
Cheng K · Endocrinology · 1989
In vitro (cells) · rat · 16 results
- Stimulatory effect of growth hormone-releasing hormone (GHRH(1-29)NH2) on the proliferation, VEGF and chromogranin A secretion by human neuroendocrine tumor cell line NCI-H727 in vitro.
Stepień T · Neuropeptides · 2009
In vitro (cells) · 3 results
- Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist.
Seitz S · Oncology reports · 2008
In vitro (cells) · 3 results
- Study of the activation mechanism of human GRF(1-29)NH2 on rat mast cell histamine release.
Estévez MD · Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 1995
In vitro (cells) · rat · 9 results
- Histamine release on rat pleural and peritoneal mast cells elicited by human GRF(1-29)NH2.
Estévez MD · International archives of allergy and immunology · 1993
In vitro (cells) · rat · 5 results
- Presence of a bioactive and immunoreactive growth-hormone-releasing-factor-like substance in porcine placenta.
Farmer C · Biology of the neonate · 1997
Measured the body's own Sermorelin · 4 results
- Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses.
Jaffe CA · The Journal of clinical investigation · 1993
Not a test of Sermorelin alone · 9 results
- Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
Kovacs M · Endocrinology · 1997
Not a test of Sermorelin alone · 8 results
- Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies.
Cervini LA · Journal of medicinal chemistry · 1998
Not a test of Sermorelin alone · 8 results
- Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
Massoud AF · Clinical endocrinology · 1997
Not a test of Sermorelin alone · 17 results
- The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6.
Popovic V · The Journal of clinical endocrinology and metabolism · 2002
Not a test of Sermorelin alone · 9 results
- Affinity of human growth hormone-releasing factor (1-29)NH2 analogues for GRF binding sites in rat adenopituitary.
Gaudreau P · Journal of medicinal chemistry · 1992
Not a test of Sermorelin alone · 6 results
- Online large volume sample staking preconcentration and separation of enantiomeric GHRH analogs by capillary electrophoresis.
Otin J · Electrophoresis · 2023
Not a test of Sermorelin alone · 5 results
- A method for evaluation of activity of antagonistic analogs of growth hormone-releasing hormone in a superfusion system.
Rekasi Z · Proceedings of the National Academy of Sciences of the United States of America · 1993
Not a test of Sermorelin alone · 5 results
- Semisynthesis of human growth hormone-releasing factors by alpha-amidating enzyme catalyzed oxidation of glycine-extended precursors.
Bongers J · Peptide research · 1992
Not a test of Sermorelin alone · 5 results
- A potentially effective drug for patients with recurrent glioma: sermorelin.
Chang Y · Annals of translational medicine · 2021
Not a test of Sermorelin alone · 5 results
- Peptide synthesis catalyzed by the Glu/Asp-specific endopeptidase. Influence of the ester leaving group of the acyl donor on yield and catalytic efficiency.
Bongers J · International journal of peptide and protein research · 1994
Not a test of Sermorelin alone · 5 results
- Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS.
Thomas A · Drug testing and analysis · 2015
Not a test of Sermorelin alone · 6 results
- Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.
Cristea CD · Analytical biochemistry · 2023
Not a test of Sermorelin alone · 8 results
- An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.
Coppieters G · Journal of pharmaceutical and biomedical analysis · 2022
Not a test of Sermorelin alone · 10 results
- GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.
Ross RJ · Clinical endocrinology · 1987
Not a test of Sermorelin alone · 3 results
- PEGylation of growth hormone-releasing hormone (GRF) analogues.
Esposito P · Advanced drug delivery reviews · 2003
Not a test of Sermorelin alone · 3 results
- Applications of BOP reagent in solid phase synthesis. Advantages of BOP reagent for difficult couplings exemplified by a synthesis of [Ala 15]-GRF(1-29)-NH2.
Fournier A · International journal of peptide and protein research · 1988
Not a test of Sermorelin alone · 3 results
- Comparison of magnetic bead surface functionalities for the immunopurification of growth hormone-releasing hormones prior to liquid chromatography-high resolution mass spectrometry.
Pont L · Journal of chromatography. A · 2020
Not a test of Sermorelin alone · 7 results
- Enzymatic semisynthesis of a superpotent analog of human growth hormone-releasing factor.
Bongers J · Journal of medicinal chemistry · 1992
Not a test of Sermorelin alone · 3 results
- Effects of calcitonin on GH response to pyridostigmine in combination with hGHRH (1-29) NH2 in normal adult subjects.
Giustina A · Clinical endocrinology · 1990
Not a test of Sermorelin alone · 3 results
- New analogs of human growth hormone-releasing hormone (1-29) with high and prolonged antagonistic activity.
Toth K · The journal of peptide research : official journal of the American Peptide Society · 1998
Not a test of Sermorelin alone · 3 results
- Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.
Uçaktürk E · Journal of pharmaceutical and biomedical analysis · 2026
Not a test of Sermorelin alone · 9 results
- A glucagon-secretin-like peptide stimulates the intrinsic nervous plexus of guinea pig gallbladder.
Greco AV · Experientia · 1990
Not a test of Sermorelin alone · 3 results
- Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist.
Waelbroeck M · Endocrinology · 1985
Not a test of Sermorelin alone · 4 results
- Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation.
Pandya N · The Journal of clinical endocrinology and metabolism · 1998
Not a test of Sermorelin alone · 4 results
- GHRH antagonist MZ-5-156 increases the expression of AMPK in A549 lung cancer cells.
Siejka A · Cell cycle (Georgetown, Tex.) · 2011
Not a test of Sermorelin alone · 2 results
- Advances in the detection of growth hormone releasing hormone synthetic analogs.
Memdouh S · Drug testing and analysis · 2021
Not a test of Sermorelin alone · 6 results
- Delayed release formulation of the somatostatin analog RC-160 inhibits the growth hormone (GH) response to GH-releasing factor-(1-29)NH2 and decreases elevated prolactin levels in rats.
Bokser L · Endocrinology · 1988
Not a test of Sermorelin alone · 2 results
- In-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptides.
González-López NM · Biomedical chromatography : BMC · 2023
Not a test of Sermorelin alone · 4 results
- Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels.
Sigalos JT · American journal of men's health · 2017
Not a test of Sermorelin alone · 6 results
- Suppression of growth hormone release restores phosphaturic response to PTH in immature rats.
Mulroney SE · The American journal of physiology · 1991
Not a test of Sermorelin alone · 2 results
- [Effect of transdermal administration of 17-beta estradiol on the release of growth hormone by growth hormone liberating hormone (GH-RH-1-29) in climacteric women before and after treatment].
Vadillo Buenfil M · Ginecologia y obstetricia de Mexico · 2001
Not a test of Sermorelin alone · 2 results
- Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency.
Garcia JM · The Journal of clinical endocrinology and metabolism · 2013
Not a test of Sermorelin alone · 1 result
- Antagonistic analogs of growth hormone releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro.
Csernus V · Peptides · 1999
Not a test of Sermorelin alone · 1 result
- Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe.
Venhuis BJ · Drug testing and analysis · 2016
Not a test of Sermorelin alone · 2 results
- Growth hormone-releasing peptides: clinical and basic aspects.
Argente J · Hormone research · 1996
Not a test of Sermorelin alone · 1 result
- Probing for peptidic drugs (2-10 kDa) in doping control blood samples.
Thomas A · Analytical science advances · 2022
Not a test of Sermorelin alone · 5 results
- Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.
Thomas A · Journal of mass spectrometry : JMS · 2024
Not a test of Sermorelin alone · 5 results
- Outcome of growth hormone therapy in children with growth hormone deficiency showing an inadequate response to growth hormone-releasing hormone.
Saenger P · Endocrine · 2001
Not a test of Sermorelin alone · 1 result